We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 13

HIPAA revises business associate agreement requirements

  • Burns & Levinson LLP
  • -
  • USA
  • -
  • May 1 2013

The privacy of health information is protected by federal rules. These rules, which have been recently updated, affect the handling of “protected

Re-publishing a third-party’s unbiased endorsement can be perilous

  • Burns & Levinson LLP
  • -
  • USA
  • -
  • February 21 2013

It should come as no surprise that making a false statement about a competitor's product or service is actionable. Similarly, albeit slightly less

Protecting the privacy of patient information under the Health Information Technology for Electronic and Clinical Health Act (HITECH Act)

  • Burns & Levinson LLP
  • -
  • USA
  • -
  • May 15 2009

On February 17, 2009, the American Recovery and Reinvestment Act of 2009 (the stimulus package) was signed into law

U.S. health care reform: what it means for employers and individuals

  • Burns & Levinson LLP
  • -
  • USA
  • -
  • April 7 2010

The Patient Protection and Affordable Care Act, a dramatic restructuring of U.S. healthcare, was signed into law on March 23, 2010, and amended by the Health Care and Education Reconciliation Act on March 31, 2010

Treasury Department releases new guidance for Therapeutic Discovery Credit or Grant program

  • Burns & Levinson LLP
  • -
  • USA
  • -
  • June 3 2010

On May 21, 2010, the U.S. Treasury Department published Notice 2010-45 (the “Notice”) which provides guidance and clarification for companies with 250 employees or less to apply for 48D certification of the Therapeutic Discovery Credit or Grant

CAFC weekly: October 8, 2010

  • Burns & Levinson LLP
  • -
  • USA
  • -
  • October 21 2010

In the only precedential opinion this week, Teva Pharmaceuticals USA, Inc. v. Eisai Co, the CAFC considered a dismissal of a declaratory judgment action

Qualifying therapeutic discovery project credit or grant

  • Burns & Levinson LLP
  • -
  • USA
  • -
  • April 23 2010

The Patient Protection and Affordable Care Act of 2010 established a new tax credit and cash grant program for certain small and mid-sized companies that engage in a "qualifying therapeutic discovery project."

CAFC weekly: November 12, 2010

  • Burns & Levinson LLP
  • -
  • USA
  • -
  • November 24 2010

The CAFC's opinions for this week include one opinion relating to prosecution laches and inequitable conduct, and four opinions relating to procedural issues (personal jurisdiction, standing, sovereign immunity and new evidence) when reviewing a Board of Appeals and Interferences (BPAI) decision using 35 USC 145

CAFC weekly: November 5, 2010

  • Burns & Levinson LLP
  • -
  • USA
  • -
  • November 10 2010

After two weeks of not handing down precedential opinions, this week the CAFC provided us with a split decision on denial of en banc review, an opinion affirming a grant of a preliminary injunction, as well as an opinion presenting an example of the usefulness of "Beauregard" claims, which are claims in which software is claimed by claiming the storage medium having the computer code embodied therein

COBRA subsidy eligibility and duration under the American Recovery and Reinvestment Act (ARRA) extended

  • Burns & Levinson LLP
  • -
  • USA
  • -
  • December 30 2009

On December 19, 2009, by signing the Fiscal 2010 Defense Appropriations Act, President Obama extended the time period for which involuntarily terminated employees would be eligible for a subsidy towards continuation of COBRA coverage and the maximum period for receiving such subsidy